Pharma Journalist -

SMi Reports: As part of SMi’s leading Injectables series, this year’s event will address the key drivers of the pre-filled syringes and combination products industry Delegates stand…
Read More...

Amgen and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083, which is Kyowa Kirin's potential first-in-class, Phase 3-ready anti-OX40 fully human…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that it has entered into an agreement with Thermo Fisher Scientific (NYSE: TMO)…
Read More...

POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, announced today that the U.S.…
Read More...

Alkermes plc announced that the U.S. Food and Drug Administration (FDA) has approved LYBALVI (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the…
Read More...

NRx Pharmaceuticals announced it has filed an application with U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for ZYESAMI (Aviptadil-acetate), to…
Read More...

Amgen and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083, which is Kyowa Kirin's potential first-in-class, Phase 3-ready anti-OX40 fully human…
Read More...

ADVANZ PHARMA Corp. Limited a specialty pharmaceutical company with a strategic focus on complex medicines in Europe, announced the completion of its acquisition by a subsidiary of…
Read More...

SMi Group reports: The ‘Target Discovery for RNA Therapeutics’ workshop will be taking place on Tuesday 15th September 2021 in London, UK. SMi Group are delighted to announce that…
Read More...

Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc. ("Rosvivo"), an American new drug…
Read More...